Evidence map›Paper›PMID 27071333›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2016

Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.

Jennifer R Charlton, Valeria M Pearl, Anna R Denotti, Jonathan B Lee, Sundararaman Swaminathan, Yogesh M Scindia, Nathan P Charlton, Edwin J Baldelomar, Scott C Beeman, Kevin M Bennett

Abstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Development and Use of Human RecombinantACS applied bio materials · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Nephron number and its determinants: a 2020 update.Pediatric nephrology (Berlin, Germany) · 2021
    Article
  12. Review
  13. Mapping nephron mass in vivo using positron emission tomography.American journal of physiology. Renal physiology · 2021
    Article
  14. Article
  15. The potential application of gold-apoferritin nanocages conjugated with 2-amino-2-deoxy-glucose for imaging of breast cancer cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. In vivo measurements of kidney glomerular number and size in healthy and OsAmerican journal of physiology. Renal physiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Jennifer R CharltonUniversity of Virginia, Department of Pediatrics, Division of Nephrology, Charlottesville VA, USA. Electronic address: jrc6n@virginia.edu.
Valeria M PearlUniversity of Virginia, Department of Pediatrics, Division of Nephrology, Charlottesville VA, USA. Electronic address: vmb3f@virginia.edu.
Anna R DenottiOspedale Regionale per le Microcitemie, University of Cagliari, Italy, Department of Pediatrics. Electronic address: an.den@hotmail.it.
Jonathan B LeeEastern Virginia Medical School, Department of Pediatrics, Norfolk, VA, USA. Electronic address: jbl5c@virginia.edu.
Sundararaman SwaminathanUniversity of Virginia, Center for Immunity, Inflammation and Regenerative Medicine and Department of Medicine, Division of Nephrology, Charlottesville VA, USA. Electronic address: ss4sa@virginia.edu.
Yogesh M ScindiaUniversity of Virginia, Center for Immunity, Inflammation and Regenerative Medicine and Department of Medicine, Division of Nephrology, Charlottesville VA, USA. Electronic address: ys9t@virginia.edu.
Nathan P CharltonUniversity of Virginia, Department of Emergency Medicine, Division of Medical Toxicology, Charlottesville, VA, USA. Electronic address: npc8a@virginia.edu.
Edwin J BaldelomarUniversity of Hawaii at Manoa, Department of Physics, Honolulu, HI, USA. Electronic address: ebaldelo@hawaii.edu.
Scott C BeemanWashington University School of Medicine, Department of Radiology, St. Louis, MO, USA. Electronic address: beemans@mir.wustl.edu.
Kevin M BennettUniversity of Hawaii at Manoa, Department of Biology, Honolulu, HI. Electronic address: kevinben@hawaii.edu.
University of Virginia · USUniversity of Hawaiʻi at Mānoa · USEastern Virginia Medical School · USUniversity of Cagliari · ITUniversity of Virginia Medical Center · USWashington University in St. Louis · US

Funding

Targeting Cellular Iron Dynamics for Protection in Kidney InjuryR01DK103043 · NIDDK · UNIVERSITY OF VIRGINIA · PI SWAMINATHAN, SUNDARARAMAN · 2015 to 2019
$1.8M
MRI Techniques to Measure Whole-Kidney NephronR21DK091722 · NIDDK · UNIVERSITY OF HAWAII AT MANOA · PI BENNETT, KEVIN M · 2012 to 2013
$399k
NIDDK NIH HHS R01 DK103043NIDDK NIH HHS R21 DK091722
6 · The paper itself

Abstract

Ferritin is a naturally occurring iron storage protein, proposed as a clinically relevant nanoparticle with applications as a diagnostic and therapeutic agent. Cationic ferritin is a targeted, injectable contrast agent to measure kidney microstructure with MRI. Here, the toxicity of horse spleen ferritin is assessed as a step to clinical translation. Adult male mice received cationic, native and high dose cationic ferritin (CF, NF, or HDCF) or saline and were monitored for 3weeks. Transient weight loss occurred in the ferritin groups with no difference in renal function parameters. Ferritin-injected mice demonstrated a lower serum iron 3weeks after administration. In ferritin-injected animals pre-treated with hydrocortisone, there were no structural or weight differences in the kidneys, liver, lung, heart, or spleen. This study demonstrates a lack of significant detrimental effects of horse-derived ferritin-based nanoparticles at MRI-detectable doses, allowing further exploration of these agents in basic research and clinical diagnostics.

Indexed as

Contrast MediaFerritinsNanoparticlesAnimalsHorsesIronLiverMagnetic Resonance ImagingMaleMiceContrast MediaFerritinsIronCationic ferritinFerritinKidneyMagnetic resonance imagingNephron numberToxicity

Identifiers

PMID27071333
PMCPMC4955692
OpenAlexW2321895518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.